COVID-19: MSN Laboratories initiates Phase III clinical trial of Molnupiravir

May 26, 2021

New Delhi [India], May 26 : MSN Laboratories Private Limited (MSN) is initiating phase III clinical trial of Molnupiravir capsules for the treatment of...

MSN Laboratories Earns Great Place to Work® Certification: A Celebration of Its People

Jul 30, 2024

Hyderabad (Telangana) [India], July 30: MSN Laboratories is delighted to announce its recognition as a Great Place to Work® by the esteemed Great Place...

MSN Laboratories enters into licence agreement with DRDO for 2 DG

Jul 09, 2021

Hyderabad (Telangana) [India], July 9 : MSN Laboratories Pvt. Ltd. (MSN) on Friday announced that it has entered into a licence agreement with the...

Lilly signs 3 more pacts to accelerate availability of baricitinib for Covid-19 patients

May 13, 2021

New Delhi [India], May 13 : Eli Lilly and Company said on Thursday it has issued additional royalty-free, non-exclusive voluntary licenses to Dr Reddy's...

Efforts to get NABL accreditation step in the right direction: AIIMS Director

Apr 17, 2024

AIIMS Director M Srinivas has praised AIIMS New Delhi's endeavour to seek National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation for its...

COVID-19: From ascertaining variants to surveillance strategy, all you need to know about Indian SARS-CoV-2 Genomics Consortium

Jul 07, 2021

New Delhi [India], July 7 : The Indian SARS-CoV-2 Genomics Consortium (INSACOG) is a national multi-agency consortium of Genome Sequencing Laboratories laboratories established by...